Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 9
Submit an article Journal homepage
188
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Targeted therapy with kinase inhibitors in aggressive endocrine tumors

Vincenzo MarottaFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
, MD,
Maria Domenica FranzeseFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
,
Michela Del PreteFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
,
Maria Grazia ChiofaloNational Cancer Institute, Endocrinology, Fondazione G. Pascale Naples, Italy
,
Valeria RamundoFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
,
Raffaella EspositoFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
,
Francesca MarcielloFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
,
Luciano PezzulloNational Cancer Institute, Endocrinology, Fondazione G. Pascale Naples, Italy
,
Annachiara CarratùFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
,
Mario VitaleUniversity of Salerno, Department of Medicine and Surgery, Baronissi, Italy
,
Annamaria ColaoFederico II University, Department of Clinical Medicine and Surgery, Via Sergio Pansini, 80131, Naples, Italy+0039817464737; +0039815465443; [email protected]
&
Antongiulio FaggianoNational Cancer Institute, Endocrinology, Fondazione G. Pascale Naples, Italy
 show all
Pages 1187-1203 | Published online: 16 May 2013

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Silvia Martina Ferrari, Ugo Politti, Roberto Spisni, Gabriele Materazzi, Enke Baldini, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli & Poupak Fallahi. (2015) Sorafenib in the treatment of thyroid cancer. Expert Review of Anticancer Therapy 15:8, pages 863-874.
Read now

Articles from other publishers (14)

Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, Gilda Varricchi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Salvatore Benvenga & Alessandro Antonelli. (2022) Molecular targets of tyrosine kinase inhibitors in thyroid cancer. Seminars in Cancer Biology 79, pages 180-196.
Crossref
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Armando Patrizio, Sabrina Rosaria Paparo, Gianni Marone, Maria Rosaria Galdiero, Giovanni Guglielmi, Rudy Foddis, Alfonso Cristaudo & Alessandro Antonelli. (2022) Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin. Seminars in Cancer Biology 79, pages 203-216.
Crossref
Vincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, Antonio Daponte, Fabio Sandomenico, Paolo Vallone, Luciana Costigliola, Gerardo Botti, Franco Ionna & Luciano Pezzullo. (2021) Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm. Critical Reviews in Oncology/Hematology 162, pages 103353.
Crossref
Giulia Bresciani, Angeliki Ditsiou, Chiara Cilibrasi, Viviana Vella, Federico Rea, Marco Schiavon, Narciso Giorgio Cavallesco, Georgios Giamas, Maria Chiara Zatelli & Teresa Gagliano. (2019) EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?. Endocrine Connections 8:6, pages 680-690.
Crossref
Khushwant S. Bhullar, Naiara Orrego Lagarón, Eileen M. McGowan, Indu Parmar, Amitabh Jha, Basil P. Hubbard & H. P. Vasantha Rupasinghe. (2018) Kinase-targeted cancer therapies: progress, challenges and future directions. Molecular Cancer 17:1.
Crossref
Vincenzo Marotta, Maria Chiara Zatelli, Concetta Sciammarella, Maria Rosaria Ambrosio, Marta Bondanelli, Annamaria Colao & Antongiulio Faggiano. (2018) Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Endocrine-Related Cancer 25:1, pages R11-R29.
Crossref
Morimasa Kitamura, Tomomasa Hayashi, Chiaki Suzuki, Shigeru Hirano, Ichiro Tateya, Yo Kishimoto & Koichi Omori. (2017) Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report. World Journal of Surgical Oncology 15:1.
Crossref
Antongiulio Faggiano, Pasqualino Malandrino, Roberta Modica, Daniela Agrimi, Maurizio Aversano, Vincenzo Bassi, Ernesto A. Giordano, Valentina Guarnotta, Francesco A. Logoluso, Erika Messina, Vincenzo Nicastro, Vincenzo Nuzzo, Marcello Sciaraffia & Annamaria Colao. (2016) Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature. The Oncologist 21:7, pages 875-886.
Crossref
Maria Chiara Zatelli, Giuseppe Fanciulli, Pasqualino Malandrino, Valeria Ramundo, Antongiulio Faggiano, Annamaria Colao & _ _. (2016) Predictive factors of response to mTOR inhibitors in neuroendocrine tumours. Endocrine-Related Cancer 23:3, pages R173-R183.
Crossref
Vincenzo Marotta, Annamaria Colao & Antongiulio Faggiano. (2015) Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge. Endocrine 50:3, pages 824-825.
Crossref
Vincenzo Marotta, Carolina Di Somma, Manila Rubino, Concetta Sciammarella, Roberta Modica, Luigi Camera, Michela Del Prete, Francesca Marciello, Valeria Ramundo, Luisa Circelli, Pasqualina Buonomano, Annamaria Colao & Antongiulio Faggiano. (2014) Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib. Endocrine 49:3, pages 854-858.
Crossref
Omar Abdel-Rahman & Mona Fouad. (2015) Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data. Tumor Biology 36:2, pages 467-478.
Crossref
V. Marotta, C. Sciammarella, M. Vitale, A. Colao & A. Faggiano. (2015) The evolving field of kinase inhibitors in thyroid cancer. Critical Reviews in Oncology/Hematology 93:1, pages 60-73.
Crossref
Anna Guerra, Vincenzo Di Crescenzo, Alfredo Garzi, Mariapia Cinelli, Chiara Carlomagno, Massimo Tonacchera, Pio Zeppa & Mario Vitale. (2013) Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surgery 13:S2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.